A detailed history of Pro Share Advisors LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 12,368 shares of FGEN stock, worth $4,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,368
Previous 16,591 25.45%
Holding current value
$4,576
Previous $38,000 71.05%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.89 - $2.36 $3,758 - $9,966
-4,223 Reduced 25.45%
12,368 $11,000
Q1 2024

May 08, 2024

BUY
$0.73 - $2.73 $954 - $3,570
1,308 Added 8.56%
16,591 $38,000
Q4 2023

Feb 14, 2024

SELL
$0.38 - $0.91 $1,119 - $2,681
-2,947 Reduced 16.17%
15,283 $13,000
Q3 2023

Nov 13, 2023

BUY
$0.79 - $2.83 $72 - $260
92 Added 0.51%
18,230 $15,000
Q2 2023

Aug 10, 2023

BUY
$2.49 - $20.59 $3,276 - $27,096
1,316 Added 7.82%
18,138 $48,000
Q1 2023

May 11, 2023

SELL
$15.95 - $25.18 $35,137 - $55,471
-2,203 Reduced 11.58%
16,822 $313,000
Q4 2022

Feb 02, 2023

BUY
$13.27 - $17.73 $19,865 - $26,541
1,497 Added 8.54%
19,025 $304,000
Q3 2022

Nov 04, 2022

BUY
$11.4 - $14.6 $4,993 - $6,394
438 Added 2.56%
17,528 $229,000
Q2 2022

Aug 01, 2022

SELL
$7.94 - $12.96 $68,943 - $112,531
-8,683 Reduced 33.69%
17,090 $180,000
Q1 2022

May 10, 2022

SELL
$12.02 - $16.79 $73,213 - $102,267
-6,091 Reduced 19.12%
25,773 $310,000
Q4 2021

Feb 08, 2022

BUY
$9.93 - $15.39 $10,317 - $15,990
1,039 Added 3.37%
31,864 $449,000
Q3 2021

Nov 12, 2021

SELL
$10.18 - $26.64 $113,374 - $296,689
-11,137 Reduced 26.54%
30,825 $315,000
Q2 2021

Aug 13, 2021

BUY
$18.57 - $35.68 $98,068 - $188,426
5,281 Added 14.4%
41,962 $1.12 Million
Q1 2021

May 14, 2021

BUY
$31.0 - $55.72 $76,570 - $137,628
2,470 Added 7.22%
36,681 $1.27 Million
Q4 2020

Feb 09, 2021

BUY
$37.09 - $48.97 $292,491 - $386,177
7,886 Added 29.96%
34,211 $1.27 Million
Q3 2020

Nov 13, 2020

SELL
$40.47 - $45.5 $20,235 - $22,750
-500 Reduced 1.86%
26,325 $1.08 Million
Q2 2020

Aug 03, 2020

BUY
$32.57 - $42.83 $286,388 - $376,604
8,793 Added 48.76%
26,825 $1.09 Million
Q1 2020

May 15, 2020

SELL
$23.3 - $45.96 $311,334 - $614,117
-13,362 Reduced 42.56%
18,032 $627,000
Q4 2019

Feb 12, 2020

SELL
$34.58 - $48.06 $97,411 - $135,385
-2,817 Reduced 8.23%
31,394 $1.35 Million
Q3 2019

Nov 12, 2019

SELL
$36.98 - $48.45 $32,246 - $42,248
-872 Reduced 2.49%
34,211 $1.27 Million
Q2 2019

Aug 13, 2019

SELL
$35.13 - $55.53 $186,821 - $295,308
-5,318 Reduced 13.16%
35,083 $1.59 Million
Q1 2019

May 15, 2019

BUY
$42.83 - $59.91 $58,805 - $82,256
1,373 Added 3.52%
40,401 $2.2 Million
Q4 2018

Feb 14, 2019

SELL
$37.97 - $60.16 $271,751 - $430,565
-7,157 Reduced 15.5%
39,028 $1.81 Million
Q3 2018

Nov 14, 2018

BUY
$56.3 - $67.25 $69,643 - $83,188
1,237 Added 2.75%
46,185 $2.81 Million
Q2 2018

Aug 13, 2018

SELL
$44.9 - $64.95 $97,971 - $141,720
-2,182 Reduced 4.63%
44,948 $2.81 Million
Q1 2018

May 14, 2018

SELL
$45.35 - $61.65 $335,499 - $456,086
-7,398 Reduced 13.57%
47,130 $2.18 Million
Q4 2017

Feb 14, 2018

BUY
$41.95 - $60.1 $175,686 - $251,698
4,188 Added 8.32%
54,528 $2.59 Million
Q3 2017

Nov 13, 2017

BUY
$33.4 - $53.9 $306,779 - $495,071
9,185 Added 22.32%
50,340 $2.71 Million
Q2 2017

Aug 11, 2017

BUY
N/A
41,155
41,155 $1.33 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $34.7M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.